Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft® September 6, 2024
Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4) September 3, 2024